Literature DB >> 11450592

A case of generalized Hailey-Hailey disease with fatal liver injury.

M Amagai1, M Kobayashi, K Wakabayashi, M Hakuno, A Hashiguchi, T Nishikawa, J Hata.   

Abstract

We report a case of a 59-year-old man with a severe generalized form of Hailey-Hailey disease that was complicated by fatal liver injury. Erosive lesions were first noted in the axillary and perianal regions at 15 year of age, and Hailey-Hailey disease was diagnosed based on the clinical features and histologic findings in skin biopsy specimens. The patient was treated with at first topical steroids and later a low dose of a corticosteroid, but the skin lesions gradually became generalized. At 45 years of age liver dysfunction was detected after azathioprine and vinblastine treatment for the generalized skin lesions. The liver injury gradually progressed and finally the patient died. The gene responsible for Hailey-Hailey disease was recently identified as ATP2C1, and it encodes a Ca(2+)-transport ATPase with broad expression, including in skin and liver. This finding suggests that mutation of the ATP2C1 gene may give rise to an extracutaneous phenotype, such as the liver dysfunction observed in severe cases, including our own. Further accumulation of cases is necessary to determine whether this is true.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11450592

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  3 in total

Review 1.  The role of the ATP2C1 gene in Hailey-Hailey disease.

Authors:  Hao Deng; Heng Xiao
Journal:  Cell Mol Life Sci       Date:  2017-05-27       Impact factor: 9.261

2.  [Disseminated M. Hailey-Hailey].

Authors:  D Richter-Hintz; M Megahed
Journal:  Hautarzt       Date:  2003-03-07       Impact factor: 0.751

3.  Characterization of Hailey-Hailey Disease-mutants in presence and absence of wild type SPCA1 using Saccharomyces cerevisiae as model organism.

Authors:  Daniel Muncanovic; Mette Heberg Justesen; Sarah Spruce Preisler; Per Amstrup Pedersen
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.